Navigating the Agentic AI Era: Strategic Adaptation for the U.S. Pharma Commercial Industry

Written by -

Ankush Kumar, Executive Director - Technology

The rapid rise of

Agentic AI

- systems capable of independently executing tasks, learning from feedback, and adapting in real time - is rewriting the rules of enterprise technology. For those of us working in the

U.S. pharma commercial space,

especially across

data management and software development,

the change is not just incremental -it's foundational.

We're entering a new chapter where traditional pipelines and dashboards will soon be orchestrated by autonomous AI agents. And it's time to talk about what that means - practically and strategically - for

companies and employees alike.

Current Sentiment: Cautious Curiosity

There’s undeniable buzz. Conversations around intelligent agents that can self-generate reports, dynamically manage master data, or write test cases are moving from innovation labs into commercial ops meetings.

But this excitement is tempered with

healthy skepticism

- and rightly so. In a highly regulated industry like pharma, where data privacy, compliance, and accuracy are non-negotiable, “black-box AI” isn't easily trusted.

4 Big Challenges we're Facing

Legacy Infrastructure
Most pharma data ecosystems are built for batch ETL, not for real-time processing or multi-model LLMs. Our current platforms weren’t designed for this level of intelligence and interactivity.
Lack of Explainability
If an AI agent modifies a data pipeline or adjusts an MDM attribute - can we trace why and how it did so? In pharma, auditability isn’t optional.
Skills Gap
Today’s teams know SQL, Python, and ETL tools. Tomorrow’s teams will need to understand
prompt engineering, agent orchestration,
and
AI observability
- fast.
Governance at Scale
Agents that can read, write, and act across multiple systems require a whole new model of
data governance
, access control, and human oversight.

How should we Adapt?

The future isn’t about replacing people -it’s about

reimagining collaboration

between humans and AI. Here’s a practical roadmap to begin that journey:

Start with Low-Risk, High-ROI Use Cases

Use agents to automate

report generation, test data creation,

dashboard QA

- places where errors are manageable, and time savings are immediate.

Modernize your Data Layer

Clean data is the foundation. Invest in AI-ready architectures:

semantic layers, vector databases,

and

metadata catalogs

that allow agents to function effectively and securely.

Establish Internal Guardrails

Create sandbox environments, version control, and clear human-in-the-loop workflows. Agents must assist- not act unilaterally - especially in compliance-heavy areas.

Partner with Agent-Native Platforms

Not every vendor will be able to retrofit agentic capabilities. Seek out partners building with LLMs, orchestration layers, and responsible AI from the ground up.

The Upskilling Imperative

We must

prepare our people, not just our platforms.

Data Engineers
→ Need fluency in agent orchestration, LangChain, vector DBs.
Reporting Analysts
→ Should understand how to work with NLP interfaces and output verification.
MDM & QA Teams
→ Need training on prompt design, agent auditability, and feedback loops.
Developers
→ Should evolve into AI-native builders, integrating APIs with agents, not just apps.

And just as importantly, we need to cultivate

judgment, interpretability, and collaboration

- skills that no agent can replicate.

Co-Evolution, Not Competition

Agentic AI doesn’t replace us - it challenges us to

evolve our roles, rethink our workflows, and redesign how we create value.

For pharma commercial teams, the opportunity is enormous - if we lean in with the right mix of strategy, infrastructure, and human-centered thinking.

The organizations that succeed will be those who

don't just adopt AI

, but who

adapt to AI

- structurally, culturally, and operationally.

Are we ready?

Would love to hear how your teams are preparing for the agentic AI wave in pharma -let’s exchange ideas, learn from each other, and shape this transformation together.